FBP1 and ovarian carcinoma: We found that 63.08% (41/65) of ovarian cancer cell lines from the CCLE database harbored FBP1 promoter DNA methylation and the degree of methylation was negatively correlated with the FBP1 mRNA expression level (Fig. 5A).